https://www.selleckchem.com/products/nu7441.html
041-1.103, P 15) had higher ischaemic stroke risk than patients with low neutrophil-to-lymphocyte ratios ( less then 5). This was true among cancer patients both with (hazard ratio 11.598; 95% confidence interval 0.953-141.181) and without (hazard ratio 7.877; 95% confidence interval 2.351-26.389) atrial fibrillation. The neutrophil-to-lymphocyte ratio at cancer diagnosis is associated with the incidence of ischaemic stroke among cancer patients and might thus be useful for identifying patients at high risk of ischaemic stroke, allowing
Like
Comment
Share
